The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Exomic sequencing of pancreatic neuroendocrine tumors: Detection of alterations in chromatin remodeling and mTOR pathway genes.
L. A. Diaz
No relevant relationships to disclose
Y. Jiao
No relevant relationships to disclose
C. Shi
No relevant relationships to disclose
B. H. Edil
No relevant relationships to disclose
R. de Wilde
No relevant relationships to disclose
D. S. Klimstra
No relevant relationships to disclose
A. Maitra
No relevant relationships to disclose
L. H. Tang
No relevant relationships to disclose
A. L. Blackford
No relevant relationships to disclose
V. Velculescu
No relevant relationships to disclose
B. Vogelstein
No relevant relationships to disclose
K. W. Kinzler
No relevant relationships to disclose
R. H. Hruban
No relevant relationships to disclose
N. Papadopoulos
No relevant relationships to disclose